跳至主要内容
临床试验/NCT03152292
NCT03152292终止不适用

Management of Parkinson's Disease Psychosis in Actual Practice (The INSYTE Study)

ACADIA Pharmaceuticals Inc.69 个研究点 分布在 1 个国家目标入组 764 人开始时间: 2017年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
764
试验地点
69
主要终点
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice)

研究概览

简要总结

To examine the current disease progression of PDP, the clinical, economic, and humanistic impact of anti-psychotic therapy in the management of the condition in real-world settings, and the burden of the condition on patients and their caregivers

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult males and females ≥ 18 with PDP
  • Ability to understand and read English
  • Patient is willing and able to sign an Informed Consent Form (ICF), or have a Legally Authorized Representative willing and able to consent on the patient's behalf
  • Possess the symptoms commonly associated with PDP, e.g., hallucinations and delusions that cannot be reasonably attributed to other causes

排除标准

  • Patient is unwilling to participate in the non-interventional study
  • Patient is currently participating in or is planning to participate in an investigational clinical trial

结局指标

主要结局

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice)

时间窗: Approximately 36 months

Describe the safety and effectiveness of antipsychotic therapies and other treatment approaches in the management of PDP. Describe comparative clinical, economic, and humanistic outcomes of treatment approaches for both patients and caregivers, in the context of real-world medical practice settings.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (69)

Loading locations...

相似试验

The INSYTE (Management of Parkinson's Disease... | 临床试验